On the Stereoselective Pharmacokinetics of Eflornithine and Prediction of Drug Tissue to Plasma Concentration Ratios by Jansson Löfmark, Rasmus
On the Stereoselective Pharmacokinetics of Eflornithine and  
Prediction of Drug Tissue to Plasma Concentration Ratios 
 
Akademisk avhandling 
som för grundläggande av medicine doktorsexamen vid Sahlgrenska Akademin vid  
Göteborgs Universitet kommer att offentligen försvaras i Konferenscentrum Wallenberg, 
Lyktan, Medicinaregatan 20A, Göteborg,  
torsdagen den 8 oktober kl. 09:00 
 
av Rasmus Jansson Löfmark 
 
Fakultetsopponent: Professor Geoffrey T. Tucker 
University of Sheffield, Storbritannien 
 
The thesis is based on the following papers: 
I. Jansson R., Bredberg U., Ashton M. Prediction of drug tissue to plasma 
concentration ratios using a measured volume of distribution in combination with 
lipophilicity. Journal of Pharmaceutical Sciences, 2008 Jun;97(6):2324-39          
 
II. Jansson R., Malm M., Roth C., Ashton M. Enantioselective and nonlinear 
intestinal absorption of eflornithine in the rat. Antimicrobial Agents and 
Chemotherapy, 2008 Aug;52 (8):2842-8.  
 
III. Jansson-Löfmark R., Römsing S., Albers E., Ashton M. Determination of 
eflornithine enantiomers in plasma, by precolumn derivatization with o-
phtaladehyde-N-acetyl-L-cysteine and liquid chromatography with UV-detection. 
Submitted 
 
IV. Jansson-Löfmark R., Johansson C-C., Hubatsch I., Artursson P., Ashton M. 
Investigations of the enantioselective absorption and pharmacokinetics of 
eflornithine in the rat and bidirectional permeabilities in Caco-2 cells. In 
manuscript 
 
V. Jansson-Löfmark R., Björkman S., Na-Bangchang K., Doua F., Ashton M. 
Enantiospecific reassessment of the pharmacokinetics and pharmacodynamics of 





On the Stereoselective Pharmacokinetics of Eflornithine and  
Prediction of Drug Tissue to Plasma Concentration Ratios 
 
Rasmus Jansson Löfmark 
Department of Pharmacology, Institute of Neuroscience and Physiology 
The Sahlgrenska Academy, University of Gothenburg, Sweden 2009 
 
Abstract: 
Eflornithine is one of two registered drugs for the treatment of late-stage human African 
trypanosomiasis, a uniformly fatal neglected disease with sixty million people are at risk of 
being infected. Eflornithine is efficacious but the cumbersome intravenous administration 
leaves numerous patients untreated. A simplified mode of administration, preferably oral, 
would enable more patients having access to treatment. The trypanostatic agent eflornithine is 
administered as a racemate where the L – form has a several-fold greater in vitro potency 
compared to the D – enantiomer. Despite the difference in potency of the enantiomers, the 
stereoselective pharmacokinetics of eflornithine has not been considered.  
 
This thesis aimed to study L – and D – eflornithine pharmacokinetics in the rat, in Caco-2 
cells and in late-stage human African trypanosomiasis patients. A secondary aim was also to 
develop a general method for predicting drug tissue to plasma concentration ratios.  
 
In the rat, eflornithine displayed stereoselective absorption where the more potent L – form 
had an approximately 50% lower fraction absorbed compared to D – eflornithine. The 
stereoselective mechanism was not detected in the present Caco-2 cell assay. Late-stage HAT 
patients, treated with racemic oral eflornithine, had an approximate 50% lower exposure of L 
– compared to D – eflornithine, similar to those in rat. The findings suggested that previous 
attempts to develop an oral eflornithine dosage regimen have failed due to unfavorable 
stereoselective absorption. High plasma exposure for both L – and D – eflornithine were 
significantly correlated to the probability of being cured.  
 
For the secondary aim of this thesis, the novel method to predict drug tissue distribution, 
based on a measured volume of distribution in combination with drug lipophilicity performed 
reasonably well. Predicted drug tissue to plasma concentration ratios agreed reasonably well 
with experimentally determined values with 85% being within a factor of ±3 to experimental 
values (n=148).  
 
In conclusion, this thesis present the stereoselective pharmacokinetics of eflornithine that can 
give information on whether a much needed oral eflornithine can be developed or not. In 
addition, the thesis also presents a general method to predict drug tissue to plasma 
concentration ratios.  
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